Dr. Reddy’s Laboratories Limited has informed the Exchange regarding a press release dated December 19, 2022, titled “Dr. Reddy s successfully completes Phase 1 study ofDRL_TC, a proposed biosimilar of tocilizumab”…….
| Subscribe To Our Free Newsletter |
